Condition
Focal Epilepsy clinical trials and research
As of November 12, 2026, Find a Trial lists 18 Focal Epilepsy clinical trials that are recruiting, at sites in 8 countries (most in United States (8), Australia (4), France (3)). By phase: Phase 2 (4), Phase 3 (2), Early Phase 1 (1), Phase 4 (1). The most active sponsors are Rapport Therapeutics Inc. (3), Mayo Clinic (2), University of California, Davis (2). There are also 8 NIH-funded research projects on Focal Epilepsy, with $3.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 8NIH research projects
- 8Countries
Newest Focal Epilepsy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| High-density flexible microneuroelectrode mapping to guide epilepsy surgery | — | Beijing, Beijing Municipality | Recruiting | Jun 18, 2026 |
| RAP-219 for adults with focal seizures | Phase 3 | Huntsville, Alabama and 13 other locations | Recruiting | May 18, 2026 |
| Spatial scene memory testing for people with temporal lobe epilepsy having surgery | — | Sacramento, California and 1 other locations | Recruiting | May 12, 2026 |
| RAP-219 in adults with focal seizures | Phase 3 | Birmingham, Alabama and 23 other locations | Recruiting | May 4, 2026 |
| Probenecid for cluster seizures during presurgical epilepsy monitoring | Phase 2 | Paris and 1 other locations | Recruiting | Jan 6, 2026 |
| Long-term daily CB03-154 treatment for focal epilepsy | Phase 2 | Melbourne, Victoria | Recruiting | Nov 20, 2025 |
| Long-term RAP-219 treatment for adults with focal onset seizures | Phase 2 | Boise, Idaho and 6 other locations | Recruiting | Oct 21, 2025 |
| Butylphthalide for thinking and memory problems in older adults with focal epilepsy | Phase 4 | Wenzhou, Zhejiang | Recruiting | Sep 25, 2025 |
| Seizure forecasting with subscalp EEG and wearables to guide epilepsy treatment | Early Phase 1 | Scottsdale, Arizona and 2 other locations | Recruiting | Jun 10, 2025 |
| CB03-154 for adults with focal epilepsy | Phase 2 | Melbourne, Victoria | Recruiting | Sep 25, 2024 |
All recruiting trials (18)
-
High-density flexible microneuroelectrode mapping to guide epilepsy surgery
This study tests whether using high-density flexible microelectrocorticography during surgery helps guide the resection of the epileptogenic zone in people with drug-resistant focal epilepsy.
-
RAP-219 for adults with focal seizures
This study tests whether RAP-219 can reduce how often focal seizures happen in adults with focal epilepsy, compared with a placebo.
-
Spatial scene memory testing for people with temporal lobe epilepsy having surgery
This project tests whether a virtual tour memory task combined with brain recordings can show how adults with temporal lobe epilepsy recognize and recall places.
-
RAP-219 in adults with focal seizures
This study tests whether RAP-219 can safely reduce the number of focal seizures in adults with focal epilepsy compared with placebo.
-
Probenecid for cluster seizures during presurgical epilepsy monitoring
This trial tests whether probenecid can help control clusters of seizures in people with focal epilepsy during presurgical video-EEG monitoring.
-
Long-term daily CB03-154 treatment for focal epilepsy
This extension will try once-daily CB03-154 (up to 20 mg) in people with focal epilepsy who completed the prior Phase 2 study to see if it is safe, tolerated, and helps control seizures over up to two years.
-
Long-term RAP-219 treatment for adults with focal onset seizures
This trial will try RAP-219, an investigational anti-seizure medication, in adults with refractory focal seizures to see if it is safe long-term and helps reduce seizures.
-
Butylphthalide for thinking and memory problems in older adults with focal epilepsy
This trial will test whether taking butylphthalide capsules for 48 weeks improves thinking and memory in people aged 60–85 who have focal epilepsy and mild-to-moderate cognitive impairment while they continue their usual seizure medicines.
-
Seizure forecasting with subscalp EEG and wearables to guide epilepsy treatment
This trial will try using forecasts from a subscalp EEG device plus wearable data to help people with temporal-lobe focal epilepsy who have frequent disabling seizures predict and manage their seizures.
-
CB03-154 for adults with focal epilepsy
A drug called CB03-154 is being tested in adults with focal epilepsy to see if it can reduce seizures and if it is safe and tolerable, compared with placebo.
-
Thalamic recordings during SEEG in children with focal epilepsy
This will test whether adding small electrodes into specific thalamic areas during SEEG in children with focal epilepsy can identify thalamic seizure signals to help guide future targeted treatments.
-
Evaluating cognitive impairment in patients with focal cryptogenic epilepsy
This study is testing how epilepsy affects thinking skills in people with different types of epilepsy to see if brain activity patterns can help understand their cognitive challenges better.
-
Evaluation of new flexible high-density electrodes for epilepsy surgery
This study is testing new flexible electrode grids during epilepsy surgery to see if they can help improve the accuracy of the procedure for patients with lesional epilepsy.
-
Breathing techniques to prevent seizure-related breathing failure
This study is testing breathing techniques to see if they can help people with hard-to-treat epilepsy breathe better during seizures.
-
Investigating sleep and cognition in patients with focal epilepsy
This study is testing how sleep patterns affect thinking skills in people with focal epilepsy to see if new treatments can help improve both sleep and cognition.
-
Using electrical stimulation on the scalp to treat epilepsy
This study is testing if a type of electrical stimulation on the scalp can help people with different kinds of epilepsy have fewer and less severe seizures.
-
Investigating brain activity in epilepsy patients using implanted electrodes
This study is testing how brain activity in patients with hard-to-treat epilepsy can help us understand their seizures and how it affects their thinking and sleep.
-
Creating a brain atlas of cognition using SEEG recordings
This study is trying to create a detailed map of how different parts of the brain are involved in thinking and memory by using special recordings from patients with epilepsy who are getting ready for surgery.
NIH-funded research (8)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Predicting seizure patterns in focal epilepsy patients
Aims to create personalized models to forecast how often seizures will happen over time in people with focal epilepsy.
-
Patchy (mosaic) genetic changes in focal epilepsy
This project looks for mosaic (patchy) genetic mutations in brain tissue from people with mesial temporal lobe epilepsy to better understand causes and help guide future treatment choices.
-
Predicting seizure patterns for people with focal epilepsy
This project builds tools to forecast how often seizures may happen over time for people with focal epilepsy using long-term seizure records.
-
Improving electrode placement for epilepsy treatment using brain imaging techniques
This study is looking for ways to improve epilepsy treatment by using advanced imaging techniques to help doctors place electrodes more accurately in the brain, so they can better predict and manage seizures for patients who are having trouble with their epilepsy.
-
Understanding genetic changes in difficult-to-treat focal epilepsy
This study is looking at the genetic differences in the brains of people with focal epilepsy who haven't found relief from regular treatments, hoping to uncover new ways to help them feel better.
-
Understanding and predicting seizures in patients with focal epilepsy
This study is working on new ways to predict how often people with focal epilepsy might have seizures, using information from 450 patients to better understand their unique seizure patterns over time.
-
Understanding genetic mutations in difficult-to-treat focal epilepsy
This study is looking at the genetic causes of hard-to-treat epilepsy in people whose brain scans look normal, hoping to find hidden changes in their brain tissue that might explain their seizures and help improve their treatment options.
-
Identifying brain connectivity markers to predict treatment response in focal epilepsy
This study is looking at how the connections in your brain might help doctors predict how well you'll respond to epilepsy treatments, like medications or surgery, so they can find the best option for you.
Related topics
Quick answers
How many Focal Epilepsy clinical trials are recruiting right now?
18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (8 trials), Australia (4 trials), France (3 trials), China (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 3: 2, Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.